{"schema_version":"secwatch.filing_event.v1","accession":"0001729149-23-000039","form_type":"8-K","ticker":"VMD","cik":"0001729149","company_name":"VIEMED HEALTHCARE, INC.","filed_at":"2023-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.337866+00:00","generated_at":"2026-06-18T15:40:16.837953+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Viemed Healthcare reports Q4 2022 core revenue of $37.5M, up 30% YoY; full-year adjusted EBITDA $30.0M","bullets":["Q4 core net revenue $37.5M (record), +30% vs Q4 2021, +5% sequentially.","Full-year 2022 net revenue $138.8M, including $2.3M COVID-related services.","Q4 net income $2.4M; full-year net income $6.2M.","Adjusted EBITDA Q4 $9.3M; full-year $30.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001729149-23-000039","json":"https://secwatch.observer/filing/0001729149-23-000039.json","markdown":"https://secwatch.observer/filing/0001729149-23-000039.md","text":"https://secwatch.observer/filing/0001729149-23-000039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729149/000172914923000039/0001729149-23-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729149/000172914923000039/vmd-20230302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T15:40:16.837953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aa255fdcc822e367de8cff01ed2e5b068020065e","claim":"VIEMED HEALTHCARE, INC. reported three months and year ended December 31, 2022 results: revenue Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million...To, net income Net income for the quarter and year ended December 31, 2022 totaled $2.4 million and $6.2 million, respectively.","evidence_excerpt":"Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729149/000172914923000039/0001729149-23-000039-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months and year ended December 31, 2022"},{"label":"Revenue","value":"Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million...To"},{"label":"Net income","value":"Net income for the quarter and year ended December 31, 2022 totaled $2.4 million and $6.2 million, respectively"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}